comparemela.com

Latest Breaking News On - Alembic pharmaceuticals ltd - Page 23 : comparemela.com

Tata Communications Ltd leads losers in A group

Alembic Pharmaceuticals Ltd Q3FY21 consolidated PAT of Rs 292 57 crore

Borosil Renewables Ltd leads losers in A group

Alembic Pharma Q3 net up 25% as US formulations business moderates

Led by double-digit growth in its India formulations business, especially specialty drugs, Vadodara-based Alembic Pharmaceuticals Ltd (APL) posted a 24.92 per cent rise in its consolidated net profit for the third quarter of financial year 2020-21. The company saw its consolidated profit after tax (PAT) stand at Rs 292.57 crore in Q3 of FY21, up from Rs 234.19 crore in the said quarter last year. APL s consolidated total income on the other hand grew by 8.87 per cent in the said quarter at Rs 1316.86 crore, up from Rs 1209.54 crore in Q3 of previous FY 20. According to Shaunak Amin, managing director of APL, while the third quarter saw some moderation in US business after several quarters of double digit topline due to multiple factors, it was the active pharmaceutical ingredients (APIs) and India formulations business including specialty drugs that led the growth.

Alembic Pharmaceuticals Ltd board to consider quarterly results on Jan 19, 2021

Alembic Pharmaceuticals Ltd board to consider quarterly results on Jan 19, 2021 Posted On: 2021-01-07 07:33:30 (Time Zone: Arizona, USA) A Meeting of Board of Directors of Alembic Pharmaceuticals Ltd will be held on Tuesday, 19th January, 2021, to consider and approve Unaudited Financial Results of the Company for the quarter and nine months period ended 31st December, 2020. The trading window for dealing in securities of the Company which was closed from 1st January, 2021, will re-open 48 hours after the declaration of the financial results. Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.1068.95 as compared to the previous close of Rs. 1069.95. The total number of shares traded during the day was 9027 in over 705 trades.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.